Kimer Med opens $4m raise to bridge funding gap
The Nelson-based biotech startup is topping up a $10m angel investment.
Kimer Med lead scientist Rishi Pandey and biomedical laboratory technician Tanja Wiles.
Kimer Med has opened a $4 million wholesale raise through Catalist to complete its Series A funding round.
The Nelson-based biotech startup founded in 2020 is working towards developing broad-spectrum antiviral drugs, with an initial focus on a treatment for Dengue fever.
The $14m raise was first
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Subscribe Now
Monthly Premium Online Subscription
NZ$44.95 / monthly
Subscribe Now
Smartphone Only Subscription
NZ$24.95 / monthly
Subscribe Now
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly
credit card debit
Subscribe Now
Yearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Subscribe Now
Already have an account? Login
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
